For the Inventor, By the Inventor

Enter assignee name

Mountain View, CA, United States of America

Alexza Pharmaceuticals, Inc.

USPTO Granted Patents = 114

CIPO Patents = 8

EPO Patents = 16

Trademarks = 6

Forward Citations = 5,908

Loading Chart...

Loading Chart...

51 inventors (with patents filed for the assignee):

Joshua D Rabinowitz (84 out of 129 patents)

Alejandro C Zaffaroni (70 out of 122 patents)

Ron L Hale (28 out of 42 patents)

4. Martin J Wensley (25 out of 34 patents)

5. Daniel J Myers (24 out of 25 patents)

6. Peter Lloyd (19 out of 24 patents)

7. Craig C Hodges (15 out of 17 patents)

8. Dennis Solas (12 out of 47 patents)

9. Soonho Song (12 out of 12 patents)

10. Reynaldo J Quintana (11 out of 25 patents)

11. Amy Tsai Lu (10 out of 13 patents)

12. Curtis Peter Tom (9 out of 29 patents)

13. Daniel Mufson (9 out of 11 patents)

14. Daniel David Rogers (9 out of 16 patents)

15. Mingzu Lei (8 out of 9 patents)

Core Competencies:

Aerosol Drug Delivery

Inhalation Therapy

Drug Condensation Aerosols

Heating Unit Technology

Nicotine Salts

Epilepsy Treatment

Antipsychotic Delivery

Vaporization Methods

Thermal Aerosol Condensation

Rapid-Heating Drug Delivery

Diuretic Aerosols

Self-Contained Drug Units

114 patents: Sort by Forward Citations

1. 12214119 - Electrical condensation aerosol device (2025-02-04),

2. 12214118 - Electrical condensation aerosol device (2025-02-04),

3. 12138383 - Heating unit for use in a drug delivery device (2024-11-12),

4. 12133915 - Method of treating epilepsy (2024-11-05),

5. 11839714 - Heat units using a solid fuel capable of undergoing an exothermic metal oxidation-reduction reaction propagated without an igniter (2023-12-12),

6. 11717479 - Method of treating epilepsy (2023-08-08),

7. 11642473 - Heating unit for use in a drug delivery device (2023-05-09),

8. 11511054 - Use of antistatic materials in the airway for thermal aerosol condensation process (2022-11-29),

9. 11458130 - Nicotine salt with meta-salicylic acid and applications therein (2022-10-04),

10. 11241383 - Method of treating epilepsy (2022-02-08),

11. 11065400 - Aerosol forming device for use in inhalation therapy (2021-07-20),

12. 10786635 - Heat units using a solid fuel capable of undergoing an exothermic metal oxidation-reduction reaction propagated without an igniter (2020-09-29),

13. 10625033 - Heating unit for use in a drug delivery device (2020-04-21),

14. 10350157 - Drug condensation aerosols and kits (2019-07-16),

15. 10166224 - Nicotine salt with meta-salicylic acid and applications therein (2019-01-01),

Alexza Pharmaceuticals, Inc. is a biopharmaceutical company primarily focused on developing and commercializing innovative therapies for central nervous system (CNS) conditions. With a dedication to novel drug delivery systems, Alexza aims to improve treatment options and patient outcomes. Their pipeline includes potential treatments for schizophrenia, agitation, epilepsy, and other CNS disorders.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

114 Patents

#24 in Mountain View, CA

#751 in California

#3,230 in US

#6,731 in the World

Mountain View, CA, United States of America

Alexza Pharmaceuticals, Inc.

Forward Citations = 5,908

51 inventors:

Joshua D Rabinowitz (84 out of 129 patents)

Alejandro C Zaffaroni (70 out of 122 patents)

Ron L Hale (28 out of 42 patents)

4. Martin J Wensley (25 out of 34 patents)

5. Daniel J Myers (24 out of 25 patents)

Please report any incorrect information to support@idiyas.com

Loading…